|Preferred IUPAC name
Clonixic acid; CBA 93626
3D model (JSmol)
CompTox Dashboard (EPA)
|Molar mass||262.69 g·mol−1|
|Glucuronidation via UGT2B7|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Clonixin is a nonsteroidal anti-inflammatory drug (NSAID). It also has analgesic, antipyretic, and platelet-inhibitory actions. It is used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.
The glyceryl ester of clonixin, clonixeril, is also a NSAID. It was prepared by a somewhat roundabout method.
Clonixin was reacted with chloroacetonitrile and triethylamine to give 2. Heating with potassium carbonate and glycerol actonide displaced the activating group to produce ester 3, which was deblocked in acetic acid to produce clonixeril (4).
- Finch, Jay S.; Dekornfeld, Thomas J. (1971). "Clonixin: A Clinical Evaluation of a New Oral Analgesic". The Journal of Clinical Pharmacology and New Drugs. 11 (5): 371–377. doi:10.1177/009127007101100508 (inactive 31 May 2021). PMID 4935715. Retrieved 2015-05-21.CS1 maint: DOI inactive as of May 2021 (link)
- M. H. Sherlock, ZA 6802185 (1968); Chem. Abstr., 70: 96640c (1969).
- CH 534129 (1973); Chem. Abstr., 79: 18582g (1973).